|
EP0833605A1
(en)
|
1995-06-22 |
1998-04-08 |
Minnesota Mining And Manufacturing Company |
Stable hydroalcoholic compositions
|
|
US6623744B2
(en)
*
|
1995-06-22 |
2003-09-23 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
AU715468B2
(en)
*
|
1995-06-22 |
2000-02-03 |
Minnesota Mining And Manufacturing Company |
Stable hydroalcoholic compositions
|
|
US7566460B2
(en)
*
|
1995-06-22 |
2009-07-28 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
US6440980B1
(en)
*
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
|
US6582711B1
(en)
|
1997-01-09 |
2003-06-24 |
3M Innovative Properties Company |
Hydroalcoholic compositions thickened using polymers
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU4972599A
(en)
*
|
1998-07-07 |
2000-01-24 |
Transdermal Technologies, Inc. |
Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
|
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
|
JP4271869B2
(ja)
*
|
1999-02-09 |
2009-06-03 |
サムヤン コーポレイション |
経皮投与用抗嘔吐剤組成物およびこれを含む製剤
|
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
|
US6679870B1
(en)
*
|
1999-07-23 |
2004-01-20 |
Vasca, Inc. |
Methods and kits for locking and disinfecting implanted catheters
|
|
US6673363B2
(en)
*
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
|
US6645520B2
(en)
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6562370B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6562369B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
|
US6558695B2
(en)
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
|
US6562368B2
(en)
*
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20030139384A1
(en)
*
|
2000-08-30 |
2003-07-24 |
Dudley Robert E. |
Method for treating erectile dysfunction and increasing libido in men
|
|
SE0004750D0
(sv)
*
|
2000-12-19 |
2000-12-19 |
Astrazeneca Ab |
Novel formulation
|
|
CA2460352C
(en)
*
|
2001-08-17 |
2013-05-14 |
Lavipharm Laboratories Inc. |
Composition and transdermal drug delivery device
|
|
NO20014746D0
(no)
*
|
2001-09-28 |
2001-09-28 |
Clas M Kjoelberg |
Smertelindrende middel
|
|
HRP20040421B1
(hr)
*
|
2001-10-16 |
2013-05-31 |
Avanir Pharmaceuticals |
INHIBICIJA VIRUSA n-DOKOZANOLOM
|
|
DE10154324A1
(de)
*
|
2001-11-06 |
2003-08-07 |
Merz Pharma Gmbh & Co Kgaa |
Topisch applizierbare Zusammensetzungen mit externer Wirkstoffdepotbildung, deren Herstellung sowie deren Verwendung
|
|
IL163981A0
(en)
*
|
2002-03-15 |
2005-12-18 |
Unimed Pharmaceuticals Inc |
Androgen pharmaceutical composition and method fortreating depression
|
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
US20040018163A1
(en)
*
|
2002-04-29 |
2004-01-29 |
Wei Yu |
Cosmetic compositions comprising at least one dimethicone, at least one linear hydrocarbon wax and at least one compatibilizing agent
|
|
US7192599B2
(en)
*
|
2002-06-03 |
2007-03-20 |
Mmp, Inc. |
Mattifying oil-in-water emulsion
|
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
PL1668105T3
(pl)
*
|
2003-09-29 |
2019-03-29 |
Deb Ip Limited |
Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
DE102004062775A1
(de)
|
2004-12-21 |
2006-06-29 |
Stockhausen Gmbh |
Alkoholischer Pumpschaum
|
|
BRPI0608347A2
(pt)
|
2005-03-07 |
2009-12-08 |
Deb Worldwide Healthcare Inc |
composição alcoólica espumável, concentrado de composição, composição alcoólica desinfetante espumável, métodos para formar, produzir e dispensar uma espuma, dispensador não pressurizado, e, métodos para usar uma composição alcoólica de espuma para desinfecção pessoal e para produzir e aplicar a uma pele de indivìduo uma composição alcoólica de espuma desinfetante de pele
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
|
US7651990B2
(en)
*
|
2005-06-13 |
2010-01-26 |
3M Innovative Properties Company |
Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
|
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
|
GEP20125432B
(en)
|
2005-10-12 |
2012-03-26 |
Unimed Pharmaceuticals Llc |
Improved testosterone gel and use thereof
|
|
US20070148101A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Marcia Snyder |
Foamable alcoholic composition
|
|
US8167847B2
(en)
|
2006-06-22 |
2012-05-01 |
Excelsior Medical Corporation |
Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
|
|
EP1905302A1
(de)
|
2006-09-30 |
2008-04-02 |
Bayer CropScience AG |
Suspensionskonzentrate
|
|
US20080146672A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Denton Marcia Marye |
Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
|
|
US8354116B2
(en)
*
|
2007-06-18 |
2013-01-15 |
Biochemics, Inc. |
Bifunctional synthetic molecules
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
US7862877B2
(en)
*
|
2007-11-20 |
2011-01-04 |
Basic Electronics, Inc. |
Sanitary wrap
|
|
US20100272784A1
(en)
|
2009-04-28 |
2010-10-28 |
3M Innovative Properties Company |
Water-soluble pressure sensitive adhesives
|
|
DE102010004950A1
(de)
*
|
2010-01-18 |
2011-07-21 |
Remis Gesellschaft für Entwicklung und Vertrieb von technischen Elementen mbH, 50829 |
Kühlregal mit Türvorrichtung
|
|
US9296904B2
(en)
|
2010-12-20 |
2016-03-29 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
US8742022B2
(en)
|
2010-12-20 |
2014-06-03 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
CN104755562B
(zh)
|
2012-06-19 |
2017-05-17 |
3M创新有限公司 |
包含低表面能基团和羟基基团的添加剂以及涂料组合物
|
|
JP6218820B2
(ja)
|
2012-06-19 |
2017-10-25 |
スリーエム イノベイティブ プロパティズ カンパニー |
低い指紋視認性を呈する重合性非イオン性界面活性剤を含むコーティング組成物
|
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US9638452B2
(en)
*
|
2012-09-12 |
2017-05-02 |
Celltronix |
Method and scalable devices for hyper-fast cooling and warming
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
US8785426B1
(en)
|
2013-12-13 |
2014-07-22 |
Upsher-Smith Laboratories, Inc. |
Testosterone gel compositions and related methods
|
|
JP2017508808A
(ja)
*
|
2014-03-17 |
2017-03-30 |
ジー・エフ・エス.コーポレーション.エー・ユー・エス.ピー・ティー・ワイ.エル・ティー・ディーGfs Corporation Aus Pty Ltd |
抗菌性除菌剤組成物およびその使用
|
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
CN109700601B
(zh)
*
|
2019-02-02 |
2022-04-22 |
天津嘉氏堂科技有限公司 |
一种水胶体硅敷料贴
|